MiR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Li, Shujun ^a   Li, Zhigang ^a   Guo, Fengjie ^a   Qin, Xuebo ^a   Liu, Bin ^a   Lei, Zhe ^b   Song, Zuoqing ^a   Sun, Liya ^a   Zhang, Hong Tao ^b   You, Jiacong ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

ARTN; esophageal carcinoma; migration and invasion; miR 223

Indexed keywords

ARTEMIN; GELATINASE A; GELATINASE B; MESSENGER RNA; MICRORNA 105; MICRORNA 223; MICRORNA 760; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ARTN PROTEIN, HUMAN; MICRORNA; MIRN223 MICRORNA, HUMAN; NERVE PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HEK293; DOWN REGULATION; ESOPHAGUS CARCINOMA; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CARCINOMA; CELL MOTION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS;

EID: 79953196913     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-24     Document Type: Article

References (23)

1. GFRalpha3 is an orphan member of the GDNF/neurturin/persephin receptor family. RH Baloh A Gorodinsky JP Golden MG Tansey CL Keck NC Popescu EM Johnson Jr J Milbrandt, Proc Natl Acad Sci USA 1998 95 5801 5806 10.1073/pnas.95.10.5801 9576965 (Pubitemid 28224177)
2. Identification and characterization of GFRalpha-3, a novel Co-receptor belonging to the glial cell line-derived neurotrophic receptor family. CA Worby QC Vega HH Chao AF Seasholtz RC Thompson JE Dixon, J Biol Chem 1998 273 3502 3508 10.1074/jbc.273.6.3502 9452475 (Pubitemid 28109772)
3. The structure of the glial cell line-derived neurotrophic factor-coreceptor complex: insights into RET signaling and heparin binding. V Parkash VM Leppanen H Virtanen JM Jurvansuu MM Bespalov YA Sidorova P Runeberg-Roos M Saarma A Goldman, J Biol Chem 2008 283 35164 35172 10.1074/jbc.M802543200 18845535
4. Human glial cell line-derived neurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells. M Lindahl D Poteryaev L Yu U Arumae T Timmusk I Bongarzone A Aiello MA Pierotti MS Airaksinen M Saarma, J Biol Chem 2001 276 9344 9351 10.1074/jbc.M008279200 11116144
5. Artemin is oncogenic for human mammary carcinoma cells. J Kang JK Perry V Pandey GC Fielder B Mei PX Qian ZS Wu T Zhu DX Liu PE Lobie, Oncogene 2009 28 2034 2045 10.1038/onc.2009.66 19363524
6. Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. GO Ceyhan KH Schafer AG Kerscher U Rauch IE Demir M Kadihasanoglu C Bohm MW Muller MW Buchler NA Giese,, et al. Ann Surg 251 923 931 10.1097/SLA.0b013e3181d974d4 20395845
7. The neurotrophic factor artemin promotes pancreatic cancer invasion. GO Ceyhan NA Giese M Erkan AG Kerscher MN Wente T Giese MW Buchler H Friess, Ann Surg 2006 244 274 281 10.1097/01.sla.0000217642.68697.55 16858191 (Pubitemid 44305543)
8. Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells. V Pandey PX Qian J Kang JK Perry MD Mitchell Z Yin ZS Wu DX Liu T Zhu PE Lobie, Endocrinology 151 909 920 10.1210/en.2009-0979 20118197
9. Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers. Y Ito Y Okada M Sato H Sawai H Funahashi T Murase T Hayakawa T Manabe, Surgery 2005 138 788 794 10.1016/j.surg.2005.07.007 16269310 (Pubitemid 41546203)
10. Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma. DJ Marsh G Theodosopoulos K Martin-Schulte AL Richardson J Philips HD Roher L Delbridge BG Robinson, J Clin Endocrinol Metab 2003 88 1866 1872 10.1210/jc.2002-021155 12679485 (Pubitemid 36623416)
11. MicroRNAs: genomics, biogenesis, mechanism, and function. DP Bartel, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438
12. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. LP Lim NC Lau P Garrett-Engele A Grimson JM Schelter J Castle DP Bartel PS Linsley JM Johnson, Nature 2005 433 769 773 10.1038/nature03315 15685193 (Pubitemid 40292988)
13. Impaired microRNA processing enhances cellular transformation and tumorigenesis. MS Kumar J Lu KL Mercer TR Golub T Jacks, Nat Genet 2007 39 673 677 10.1038/ng2003 17401365 (Pubitemid 46676103)
14. Oncomirs - microRNAs with a role in cancer. A Esquela-Kerscher FJ Slack, Nat Rev Cancer 2006 6 259 269 10.1038/nrc1840 16557279
15. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. J Brennecke DR Hipfner A Stark RB Russell SM Cohen, Cell 2003 113 25 36 10.1016/S0092-8674(03)00231-9 12679032 (Pubitemid 36411957)
16. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Y Guo Z Chen L Zhang F Zhou S Shi X Feng B Li X Meng X Ma M Luo,, et al. Cancer Res 2008 68 26 33 10.1158/0008-5472.CAN-06-4418 18172293 (Pubitemid 351380102)
17. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. EA Mathe GH Nguyen ED Bowman Y Zhao A Budhu AJ Schetter R Braun M Reimers K Kumamoto D Hughes,, et al. Clin Cancer Res 2009 15 6192 6200 10.1158/1078-0432.CCR-09-1467 19789312
18. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. JA Pulikkan V Dengler PS Peramangalam AA Peer Zada C Muller-Tidow SK Bohlander DG Tenen G Behre, Blood 115 1768 1778 10.1182/blood-2009-08-240101 20029046
19. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. B Stamatopoulos N Meuleman B Haibe-Kains P Saussoy E Van Den Neste L Michaux P Heimann P Martiat D Bron L Lagneaux, Blood 2009 113 5237 5245 10.1182/blood-2008-11-189407 19144983
20. MicroRNA-223 is a key factor in osteoclast differentiation. T Sugatani KA Hruska, J Cell Biochem 2007 101 996 999 10.1002/jcb.21335 17471500 (Pubitemid 47040879)
21. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. QW Wong RW Lung PT Law PB Lai KY Chan KF To N Wong, Gastroenterology 2008 135 257 269 10.1053/j.gastro.2008.04.003 18555017 (Pubitemid 351910680)
22. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. JB Johnnidis MH Harris RT Wheeler S Stehling-Sun MH Lam O Kirak TR Brummelkamp MD Fleming FD Camargo, Nature 2008 451 1125 1129 10.1038/nature06607 18278031 (Pubitemid 351317447)
23. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. A Laios S O'Toole R Flavin C Martin L Kelly M Ring SP Finn C Barrett M Loda N Gleeson,, et al. Mol Cancer 2008 7 35 10.1186/1476-4598-7-35 18442408